Mitochondrial decline precedes phenotype development in the complement factor H mouse model of retinal degeneration

Karin C Calaza1, Jaimie Hoh Kam2, Chris Hogg3

  • 1Program of Neurosciences, Institute of Biology, Federal Fluminense University, Rio de Janeiro, Brazil; Institute of Ophthalmology University College London, London, UK.

Insights

Mitochondrial adenosine triphosphate (ATP) decline in a mouse model of age-related macular degeneration was reversed by near-infrared light. This light therapy improved retinal ATP levels and mitochondrial stress markers.

Area of Science:

  • Mitochondrial biology
  • Neuroscience
  • Ophthalmology

Background:

  • Mitochondria are vital for cellular energy production through adenosine triphosphate (ATP).
  • Age-related decline in ATP is linked to inflammation and cellular dysfunction.
  • Complement factor H knockout mice serve as a model for age-related macular degeneration (AMD).

Purpose of the Study:

  • To investigate retinal and brain ATP levels in a mouse model of AMD.
  • To explore the therapeutic potential of near-infrared (NIR) light on mitochondrial function and inflammation in this model.

Main Methods:

  • Measurement of retinal and brain ATP levels in C57BL/6 and Cfh(-/-) mice.
  • Analysis of heat shock protein 60 (Hsp60) expression as a mitochondrial stress marker.
  • Application of near-infrared (NIR) light therapy to Cfh(-/-) mice.

Main Results:

  • A significant 30% premature decline in retinal ATP was observed in Cfh(-/-) mice.
  • NIR therapy successfully corrected the retinal ATP decline and altered Hsp60 expression patterns.
  • No differences in brain ATP were found between the mouse groups.

Conclusions:

  • Mitochondrial dysfunction, indicated by ATP decline, may underlie AMD pathogenesis.
  • NIR light therapy demonstrates potential for improving mitochondrial function and addressing AMD.
  • Early ATP decline precedes inflammation and photoreceptor loss in the AMD mouse model.